Morning Report: Lloyds ends PPI headache; Sirius Minerals 'is quality' says Anglo

Headlines from the Proactive UK newsroom.

Anglo American (LON:AAL) has repeated that Sirius Minerals (LON:SXX) is a “quality” investment which is expected to “fit well” with the FTSE 100 group’s strategy. Anglo, which has made a bid for the firm, says the project in North Yorkshire is attractive in terms of scale, resource life and operating cost profile.

Lloyds (LON:LLOY) has posted higher fourth quarter profits as it finally stopped paying PPI. Profits for the year however fell 26% to £4.4bn after PPI cost it £2.45bn and low interest rates hit margins. 

Greencoat UK Wind (LON:UKW) has agreed to acquire a wind farm in County Tyrone for £51mln.The farm was constructed by SSE and has been operational since June 2017.

Advanced Oncotherapy (LON:AVO) is to install one of its ‘Light’ proton beam systems at University Hospitals Birmingham.

Falcon Oil & Gas (LON:FOG) has successfully completed the drilling of its latest horizontal well at the Beetaloo shale project, in Australia. The well included a 1,579m lateral in the Lower Kyalla formation.

Virtual reality group Immotion (LON:IMMO) has signed contracts for 68 headsets in the past week to take the number on order or in operation to 432.

Sativa subsidiary (LON:SATI), Goodbody Botanicals, has secured a CBD product listing agreement with WH Smith Travel. Products will be stocked in around 100 of the retailer’s highest footfall outlets.

Hays (LON:HAS) is bracing for a slump in temp activity when changes to the UK tax rules for contractors come into force in April. The recruiter says the UK jobs market remains subdued which was also hit by a £3mln foreign currency charge in the past month.

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events


The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...


2 min read